线粒体DNA序列变异与脑膜瘤风险
该病例对照研究纳入美国东南部478例脑膜瘤患者和1080例对照,检测42个常见线粒体DNA变异、单倍群及基因与脑膜瘤的关联。结果显示常见mtDNA变异和主要单倍群整体与脑膜瘤风险无关,但m.16362T>C与WHO II/III级脑膜瘤相关,L单倍群在自我报告白种人中关联显著。
要点
- 常见mtDNA变异及主要单倍群整体与脑膜瘤风险无显著关联
- m.16362T>C与WHO II/III级脑膜瘤风险升高相关(OR 2.33)
- L单倍群仅在少数自我报告白种人中与脑膜瘤相关
核心结论
- 常见mtDNA变异和主要mtDNA单倍群似乎与脑膜瘤发生风险无关。
研究设计与样本
- 在美国东南部医疗中心开展病例对照研究,纳入1080例对照和478例脑膜瘤病例。
- 检测42个常见胚系mtDNA变异(次要等位基因频率≥5%)、单倍群及基因。
- 分别分析整体脑膜瘤及按WHO分级(409例I级、69例II/III级)的关联。
主要发现
- 整体脑膜瘤与女性(OR 2.85;95%CI 2.21-3.69)、自我报告非裔美国人种族(OR 2.38,95%CI 1.41-3.99)、超重(OR 1.48;95%CI 1.11-1.97)或肥胖(OR 1.70;95%CI 1.25-2.31)显著相关。
- 线粒体控制区变异m.16362T>C(rs62581341)与II/III级脑膜瘤正相关(OR 2.33;95%CI 1.14-4.77),但与I级肿瘤无关(OR 0.99;95%CI 0.64-1.53)。
- 单倍群L(非洲祖先标记)与整体脑膜瘤相关(OR 2.92;95%CI 1.01-8.44),但按自我报告种族分层后仅在少数携带该单倍群的自我报告白种人中显著(OR 6.35;95%CI 1.56-25.9)。
- 未发现其他mtDNA变异、单倍群或基因与脑膜瘤相关。
临床怎么用
- 常见mtDNA变异暂不宜作为脑膜瘤风险筛查或分级的常规标志物。
- m.16362T>C与高级别脑膜瘤的关联需进一步验证,目前不推荐临床常规检测。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Risk factors for meningioma include female gender, African American race, high body mass index (BMI), and exposure to ionizing radiation. Although genome-wide association studies (GWAS) have identified two nuclear genome risk loci for meningioma (rs12770228 and rs2686876), the relation between mitochondrial DNA (mtDNA) sequence variants and meningioma is unknown. METHODS: We examined the association of 42 common germline mtDNA variants (minor allele frequency ≥ 5%), haplogroups, and genes with meningioma in 1080 controls and 478 meningioma cases from a case-control study conducted at medical centers in the southeastern United States. Associations were examined separately for meningioma overall and by WHO grade (n = 409 grade I and n = 69 grade II/III). RESULTS: Overall, meningioma was significantly associated with being female (OR 2.85; 95% CI 2.21-3.69), self-reported African American race (OR 2.38, 95% CI 1.41-3.99), and being overweight (OR 1.48; 95% CI 1.11-1.97) or obese (OR 1.70; 95% CI 1.25-2.31). The variant m.16362T > C (rs62581341) in the mitochondrial control region was positively associated with grade II/III meningiomas (OR 2.33; 95% CI 1.14-4.77), but not grade I tumors (OR 0.99; 95% CI 0.64-1.53). Haplogroup L, a marker for African ancestry, was associated with meningioma overall (OR 2.92; 95% CI 1.01-8.44). However, after stratifying by self-reported race, this association was only apparent among the few self-reported Caucasians with this haplogroup (OR 6.35; 95% CI 1.56-25.9). No other mtDNA variant, haplogroup, or gene was associated with meningioma. CONCLUSION: Common mtDNA variants and major mtDNA haplogroups do not appear to have associations with the odds of developing meningioma.
引用
- Samanic CM, Teer JK, Thompson ZJ, et al. Mitochondrial DNA sequence variation and risk of meningioma. J Neurooncol. 2021. PMID: 34669147. doi:10.1007/s11060-021-03878-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。